Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Expanded Access Guidances Fail To Achieve Détente With Advocates

May 27 2013

• By Sarah Karlin-Smith

Related Content

<i>Zelboraf</i> Approval Hastened By FDA Officials Impressed With Early Efficacy

Aug 22 2011

FDA Rules On INDs May Embolden More Patients To Ask For Trial Drugs

Aug 17 2009

BIO Wants Expanded Accelerated Approval In PDUFA Instead Of Progressive Approval

Jan 23 2012

FDA “Breakthrough” Designation Bill Revives Debate About Legislating Flexibility

Mar 27 2012

Making Expanded Access Programs Work For - Not Against - Your Trial Drug

Jun 07 2010

Access To Investigational Drugs Remains Challenge Despite New FDA Rules

Mar 29 2010

Related Companies

Genentech, Inc.

Genentech, Inc.

Roche Holding AG

Additional Topics

United States Regulation BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window